Terms ending in 2033
Every in-force patent on Ablynx N.V.'s record whose computed term ends in 2033, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 9,193,780 | Amino Acid Sequences Directed Against Envelope Proteins of a Virus and Polypeptides Comprising the Same for the Treatment of Viral Diseases In force · High confidence | Ablynx N.V. | In force | High confidence | |
| US 9,670,275 | Sequences Directed Against Hepatocyte Growth Factor (HGF) and Polypeptides Comprising the Same for the Treatment of Cancers And/Or Tumors In force · High confidence | Ablynx N.V. | In force | High confidence | |
| US 10,100,110 | Sequences Directed Against Hepatocyte Growth Factor (HGF) and Polypeptides Comprising the Same for the Treatment of Cancers And/Or Tumors In force · High confidence | Ablynx N.V. | In force | High confidence | |
| US 9,212,226 | Amino Acid Sequences Directed Against CXCR4 and Other Gpcrs and Compounds Comprising the Same In force · High confidence | Ablynx N.V. | In force | High confidence | |
| US 9,458,235 | Method for Treating a CX3CR1-ASSOCIATED Disease with CX3CR1-BINDING Polypeptides In force · High confidence | Ablynx N.V. | In force | High confidence | |
| US 11,384,151 | CX3CR1-BINDING Polypeptides Comprising Immunoglobulin Single Variable Domains In force · High confidence | Ablynx N.V. | In force | High confidence | |
| US 10,072,098 | Pseudomonas Aeruginosa PCRV Binding Single Variable Domain Antibodies In force · High confidence | Ablynx N.V. | In force | High confidence | |
| US 9,783,612 | CX3CR1-BINDING Polypeptides In force · High confidence | Ablynx N.V. | In force | High confidence | |
| US 9,534,039 | Method for the Production of Immunoglobulin Single Variable Domains In force · High confidence | Ablynx N.V. | In force | High confidence | |
| US 10,385,134 | CX3CR1-BINDING Polypeptides Comprising Immunoglobulin Single Variable Domains In force · High confidence | Ablynx N.V. | In force | High confidence | |
| 9 more term ends in 2033 · Pro | |||||
10 of 19 patents shown. Soonest term end first, then patent number.
Pro members see all 19.
16 of these are in force and held by Ablynx N.V..
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.